BIOMEX at MedTech Summit in Brussels
Our participation in the medtech Summit in Brussels was a great success. For two days we had the chance to talk to companies, other experts and innovators from the diagnostic industry. For the first time our colleagues Thomas Dillig and Heike Lukhaup had the opportunity to present our 𝗵𝗶𝗴𝗵𝗹𝘆 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝗶𝘇𝗲𝗱 𝗜𝘃𝗗 𝘀𝘁𝘂𝗱𝗶𝗲𝘀 including HIV, HBV, Influenza A/B and many more, which will be Read More
BIOMEX at CACLP in Nanchang
The CACLP is back and BIOMEX will be there too! Join our colleague, Lu Li, at the Nanchang Greenland International Expo Center from May 28th to May 30th. If you’re attending the event and need specific advice on the requirements of the European IVDR, assistance with regulatory validation studies, or biospecimens from a highly specialized German supplier, Read More
High quality cord blood derived products available
Are you looking for a sustainable source for high quality cord blood derived products? Only the best for our customers: BIOMEX controls and manages the entire process from collecting of the cord blood, through logistics, automated cell isolation and quality control, to the delivery of the product. In addition to peripheral blood mononuclear cells (PBMCs) Read More
New Biosafety L2 (partly L3) level lab for processing human material
We are more than happy to announce that BIOMEX is continuing its expansion and now offers a new Biosafety L2 (partly L3) level lab for processing human material. It allows us to isolate proteins and cells from human liquids, tissue and blood products. This way, we can process leukopaks, isolate PBMCs and also sub-populations of Read More
EMPOWERING SCIENTISTS – BIOMEX with new claim and mission
Making success possible is our definition of success Our new slogan “EMPOWERING SCIENTISTS” reflects what we have been working on day by day for more than 30 years. We remain in the background and do our job with passion and a high demand on ourselves. We are aware that success does not happen overnight. And Read More
BIOMEX with expanded portfolio and new logo
We are excited to share some news with you. As you may know, we are on track to provide human biosamples and premium services to the entire Life Sciences industry. Not only do we offer human material from our own donation centers and global network and have a proven track record as an experienced Clinical Read More
BIOMEX acquires Atreide
BIOMEX, Europe’s leading provider of human biospecimens and services for the diagnostics industry, announced today the acquisition of Atreide Biosamples in an asset deal.
BIOMEX at CACLP in Nanchang from October 26th to 28th
BIOMEX will have its own booth at the China Association of Clinical Laboratory Practice (CACLP) Expo in Nanchang from October 26-28, 2022 and looks forward forward to seeing you there.
BIOMEX performs 130th SARS-CoV-2 assay validation
In order to meet the high demand, BIOMEX has tripled its laboratory capacities and personnel infrastructure the last few months and established the entire validation process according to the current IVD regulation.
BIOMEX supports cancer research on Burkitt’s lymphoma in children
With a donation of 40,000 euros, BIOMEX supports the excellent work of two university research groups working on Burkitt’s lymphoma in children, a fast-growing cancer of the lymphatic system.
